Shailesh Jejurikar, Chairman, President and CEO of Procter & Gamble Co, filed a Form 4 on August 20, 2026, disclosing the acquisition of common stock and restricted stock units on August 19, 2026, and August 17, 2026, respectively.
Key Highlights
- Stock award granted: Jejurikar acquired 16,195 shares of common stock on August 19, 2026, at a price of $0, pursuant to the issuer's 2025 Stock and Incentive Compensation Plan.
- Direct beneficial ownership: Following the transaction, Jejurikar directly holds 45,501.9973 shares of common stock, including dividend equivalents in the form of RSUs settled in common stock.
- RSU dividend equivalents: On August 17, 2026, Jejurikar acquired 45.2221 restricted stock units as dividend equivalents under the issuer's retirement program, at a price of $0.
- Total RSU balance: Following the RSU transaction, Jejurikar directly holds 734.2684 derivative securities (restricted stock units).
- Indirect holdings: Additional indirect beneficial ownership includes 3,741.7415 shares held by a retirement plan trustee, 19,757 shares in the Sankhya S Jejurikar Revocable Trust, and 35,836 shares in the Shailesh Jejurikar Trust.
- Filing entity: The filing covers Procter & Gamble Co, traded on NYSE:PG, and was filed by one reporting person.
Jejurikar's August 2026 Stock Transactions at Procter & Gamble
According to the Form 4 filed with the SEC on August 20, 2026, Shailesh Jejurikar, who serves as Chairman, President and CEO of Procter & Gamble Co (NYSE:PG), received a stock award of 16,195 shares of common stock on August 19, 2026. The filing identifies this as a stock award pursuant to the issuer's 2025 Stock and Incentive Compensation Plan, with the transaction coded as an acquisition at a price of $0. Following this transaction, Jejurikar's direct beneficial ownership of common stock stands at 45,501.9973 shares, which the filing notes includes a grant of dividend equivalents in the form of restricted stock units settled in common stock.
In a separate transaction reported in Table II, the filing discloses that Jejurikar acquired 45.2221 restricted stock units on August 17, 2026, also at a price of $0. These RSUs are described as "dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program," and represent "a contingent right to receive Procter & Gamble common stock." The filing states these units will deliver in shares on retirement from the company, unless delivery is deferred or the shares are contributed to the reporting person's deferred compensation account. Following this transaction, Jejurikar's direct holding of RSUs totals 734.2684.
In addition to direct holdings, the filing reports indirect beneficial ownership of common stock: 3,741.7415 shares held by a retirement plan trustee, 19,757 shares held through the Sankhya S Jejurikar Revocable Trust, and 35,836 shares held through the Shailesh Jejurikar Trust. The form was signed by Wednesday Shipp as attorney-in-fact for Shailesh Jejurikar on August 20, 2026.
What Was Disclosed
The filing reports two non-cash acquisitions by Procter & Gamble's Chairman, President and CEO: a stock award of 16,195 common shares under the 2025 Stock and Incentive Compensation Plan, and 45.2221 RSUs as retirement program dividend equivalents, both at zero cost.




Please wait processing your request...